COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
复制标题
DOI:
10.1007/s10654-021-00728-6
复制
发表时间:
2021-03
影响因子:
13.6
通讯作者:
Wu JW
中科院分区:
文献类型:
--
作者:
Skjefte M;Ngirbabul M;Akeju O;Escudero D;Hernandez-Diaz S;Wyszynski DF;Wu JW
With the development of multiple effective vaccines, reducing the global morbidity and mortality of COVID-19 will depend on the distribution and acceptance of COVID-19 vaccination. Estimates of global vaccine acceptance among pregnant women and mothers of young children are yet unknown. An understanding of the challenges and correlates to vaccine acceptance will aid the acceleration of vaccine administration within these populations. Acceptance of COVID-19 vaccination among pregnant women and mothers of children younger than 18-years-old, as well as potential predictors, were assessed through an online survey, administered by Pregistry between October 28 and November 18, 2020. 17,871 total survey responses from 16 countries were obtained. Given a 90% COVID-19 vaccine efficacy, 52.0% of pregnant women (n = 2747/5282) and 73.4% of non-pregnant women (n = 9214/12,562) indicated an intention to receive the vaccine. 69.2% of women (n = 11,800/17,054), both pregnant and non-pregnant, indicated an intention to vaccinate their children. Vaccine acceptance was generally highest in India, the Philippines, and all sampled countries in Latin America; it was lowest in Russia, the United States and Australia. The strongest predictors of vaccine acceptance included confidence in vaccine safety or effectiveness, worrying about COVID-19, belief in the importance of vaccines to their own country, compliance to mask guidelines, trust of public health agencies/health science, as well as attitudes towards routine vaccines. COVID-19 vaccine acceptance and its predictors among women vary globally. Vaccination campaigns for women and children should be specific for each country in order to attain the largest impact. The online version contains supplementary material available at 10.1007/s10654-021-00728-6.
登录
查看更多内容
DOI:
10.15585/mmwr.mm6944e3
发表时间:
2020-11-06
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Zambrano LD;Ellington S;Strid P;Galang RR;Oduyebo T;Tong VT;Woodworth KR;Nahabedian JF 3rd;Azziz-Baumgartner E;Gilboa SM;Meaney-Delman D;CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team
通讯作者:
CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team
影响因子:
4.3
作者:
Collin, Julius;Bystrom, Emma;Ahrne, Malin
通讯作者:
Ahrne, Malin
DOI:
10.15585/mmwr.mm6938e1
发表时间:
2020-09-25
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Delahoy MJ;Whitaker M;O'Halloran A;Chai SJ;Kirley PD;Alden N;Kawasaki B;Meek J;Yousey-Hindes K;Anderson EJ;Openo KP;Monroe ML;Ryan PA;Fox K;Kim S;Lynfield R;Siebman S;Davis SS;Sosin DM;Barney G;Muse A;Bennett NM;Felsen CB;Billing LM;Shiltz J;Sutton M;West N;Schaffner W;Talbot HK;George A;Spencer M;Ellington S;Galang RR;Gilboa SM;Tong VT;Piasecki A;Brammer L;Fry AM;Hall AJ;Wortham JM;Kim L;Garg S;COVID-NET Surveillance Team
通讯作者:
COVID-NET Surveillance Team
影响因子:
3.3
作者:
Morimoto, Akiko;Ueda, Yutaka;Takagi, Tetsu
通讯作者:
Takagi, Tetsu
DOI:
10.15585/mmwr.mm6938e2
发表时间:
2020-09-23
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Panagiotakopoulos L;Myers TR;Gee J;Lipkind HS;Kharbanda EO;Ryan DS;Williams JTB;Naleway AL;Klein NP;Hambidge SJ;Jacobsen SJ;Glanz JM;Jackson LA;Shimabukuro TT;Weintraub ES
通讯作者:
Weintraub ES